Perspective Therapeutics, Inc. — Director's Dealing 2009

Oct 15, 2009

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2009-10-02

Reporting Person: Ragle Brien (Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock option	$4.4	2017-03-02	common stock (5000)		Direct
Stock option	$4.14	2017-06-01	common stock (2000)		Direct
Stock option	$0.26	2019-06-01	common stock (34000)		Direct

Footnotes

F1: 3,334 are exercisable as of the date of this Form 3, and 1,666 will become exercisable on March 2, 2010.

F2: 1,333 are exercisable as of the date of this Form 3, and 667 will become exercisable on June 1, 2010.

F3: 11,333 will become exercisable on June 1, 2010, 11,333 will become exercisable on June 1, 2011, and 11,334 will become exercisable on June 1, 2012.